Lymphodepletion with total body irradiation (TBI) increases the efficacy of adoptively transferred tumor-specific CD8+ T cells by depleting inhibitory lymphocytes and increasing homeostatic cytokine levels. We found that TBI augmented the function of adoptively transferred CD8+ T cells in mice genetically deficient in all lymphocytes, indicating the existence of another TBI mechanism of action. Additional investigation revealed commensal gut microflora in the mesenteric lymph nodes and elevated LPS levels in the sera of irradiated mice. These findings correlated with increased dendritic cell activation and heightened levels of systemic inflammatory cytokines. Reduction of host microflora using antibiotics, neutralization of serum LPS using polymyxin B, or removal of LPS signaling components using mice genetically deficient in CD14 and TLR4 reduced the beneficial effects of TBI on tumor regression. Conversely, administration of microbial ligand–containing serum or ultrapure LPS from irradiated animals to nonirradiated antibody-lymphodepleted mice enhanced CD8+ T cell activation and improved tumor regression. Administration of ultrapure LPS to irradiated animals further enhanced the number and function of the adoptively transferred cells, leading to long-term cure of mice with large B16F10 tumors and enhanced autoimmune vitiligo. Thus, disruption of the homeostatic balance between the host and microbes can enhance cell-based tumor immunotherapy.
Chrystal M. Paulos, Claudia Wrzesinski, Andrew Kaiser,, Christian S. Hinrichs, Marcello Chieppa, Lydie Cassard, Douglas C. Palmer, Andrea Boni, Pawel Muranski, Zhiya Yu, Luca Gattinoni, Paul A. Antony, Steven A. Rosenberg, Nicholas P. Restifo
Title and authors | Publication | Year |
---|---|---|
Tumor microbiome: roles in tumor initiation, progression, and therapy
Zhang S, Huang J, Jiang Z, Tong H, Ma X, Liu Y |
Molecular Biomedicine | 2025 |
Gut microbiota as a new target for anticancer therapy: from mechanism to means of regulation
Sun J, Song S, Liu J, Chen F, Li X, Wu G |
NPJ Biofilms and Microbiomes | 2025 |
Exploring effects of gut microbiota on tertiary lymphoid structure formation for tumor immunotherapy
Liu Y, Li F, Wang J, Yang R |
Frontiers in Immunology | 2025 |
Microbiota-Derived L-SeMet Potentiates CD8+ T Cell Effector Functions and Facilitates Anti-Tumor Responses
Fan S, Li Y, Huang S, Wang W, Zhang B, Zhang J, Jian X, Song Z, Wu M, Tu H, Wen Y, Li H, Li S, Hu H |
International Journal of Molecular Sciences | 2025 |
Exploring the Microbiome’s Impact on Glioma and Brain Metastases: Insights into Development, Progression, and Treatment Response—A Scoping Review
Leigh J, Skidmore B, Wong A, Maleki Vareki S, Ng TL |
Cancers | 2025 |
Gut microbiota in hepatocellular carcinoma immunotherapy: immune microenvironment remodeling and gut microbiota modification
Huang M, Ji Q, Huang H, Wang X, Wang L |
Gut Microbes | 2025 |
Immunoenhancing of the anti-cancer therapy and anti-oxidative stress by co-administration of granulocyte-colony stimulating factor-mobilized stem cells or cells derived from bone marrow and/or spleen plus vaccination with chemotherapeutic cyclophosphamide.
Gomaa S, Nassef M, Tabl G, Gabry SE |
Immunologic research | 2025 |
Infection of tumor cells with Salmonella typhimurium mimics immunogenic cell death and elicits tumor-specific immune responses
Horiuchi Y, Nakamura A, Imai T, Murakami T |
2024 | |
Oral administration of Manuka honey induces IFNγ-dependent resistance to tumor growth that correlates with beneficial modulation of gut microbiota composition
Masad RJ, Idriss I, Mohamed YA, Al-Sbiei A, Bashir G, Al-Marzooq F, Altahrawi A, Fernandez-Cabezudo MJ, Al-Ramadi BK |
Frontiers in immunology | 2024 |
Cross-reactive CD8+ T cell responses to tumor-associated antigens (TAAs) and homologous microbiota-derived antigens (MoAs)
Cavalluzzo B, Viuff MC, Tvingsholm SA, Ragone C, Manolio C, Mauriello A, Buonaguro FM, Tornesello ML, Izzo F, Morabito A, Hadrup SR, Tagliamonte M, Buonaguro L |
Journal of experimental & clinical cancer research : CR | 2024 |
Targeting the gut microbiota to enhance the antitumor efficacy and attenuate the toxicity of CAR-T cell therapy: a new hope?
Zhang PF, Xie D |
Frontiers in immunology | 2024 |
Dietary factors and their influence on immunotherapy strategies in oncology: a comprehensive review
Golonko A, Pienkowski T, Swislocka R, Orzechowska S, Marszalek K, Szczerbinski L, Swiergiel AH, Lewandowski W |
Cell Death and Disease | 2024 |
Influence of Microbiota on Tumor Immunotherapy
Yu X, Li W, Li Z, Wu Q, Sun S |
International journal of biological sciences | 2024 |
Critical role of the gut microbiota in immune responses and cancer immunotherapy.
Li Z, Xiong W, Liang Z, Wang J, Zeng Z, Kołat D, Li X, Zhou D, Xu X, Zhao L |
Journal of Hematology & Oncology | 2024 |
Efficacy and regulatory strategies of gut microbiota in immunotherapy: a narrative review.
Sang Y, Zheng K, Zhao Y, Liu Y, Zhu S, Xie X, Shang L, Liu J, Li L |
Translational cancer research | 2024 |
Intestinal Microbiome Associated with Efficacy of Atezolizumab and Bevacizumab Therapy for Hepatocellular Carcinoma.
Inukai Y, Yamamoto K, Honda T, Yokoyama S, Ito T, Imai N, Ishizu Y, Nakamura M, Ishigami M, Kawashima H |
Cancers | 2024 |
Gastric Cancer, Immunotherapy, and Nutrition: The Role of Microbiota
Raoul P, De Gaetano V, Sciaraffia G, Ormea G, Cintoni M, Pozzo C, Strippoli A, Gasbarrini A, Mele MC, Rinninella E |
Pathogens | 2024 |
Friend or Foe: Exploring the Relationship between the Gut Microbiota and the Pathogenesis and Treatment of Digestive Cancers
Profir M, Roşu OA, Creţoiu SM, Gaspar BS |
Microorganisms | 2024 |
Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies
Xie J, Liu M, Deng X, Tang Y, Zheng S, Ou X, Tang H, Xie X, Wu M, Zou Y |
iMeta | 2024 |
Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells
Wittling MC, Knochelmann HM, Wyatt MM, Rangel Rivera GO, Cole AC, Lesinski GB, Paulos CM |
Journal for ImmunoTherapy of Cancer | 2024 |
Disruption of post-thymic tolerance in skin-reactive TCR transgenic mice through the interaction of lymphopenia and intestinal microbiota
Hayabuchi H, Tokifuji Y, Takahashi H, Amagai M, Yoshimura A, Chikuma S |
International Immunology | 2024 |
Gut dysbiosis impacts the immune system and promotes prostate cancer
Shyanti RK, Greggs J, Malik S, Mishra M |
Immunology Letters | 2024 |
Strategies for Improving CAR T Cell Persistence in Solid Tumors
Wittling MC, Cole AC, Brammer B, Diatikar KG, Schmitt NC, Paulos CM |
Cancers | 2024 |
Global research trends on the links between gut microbiota and radiotherapy: a bibliometric analysis (2004-2023).
Wang S, Yuan Z, Gao X, Wu J, Ren Y, Yu X, Li J, Wei W |
Frontiers in cellular and infection microbiology | 2024 |
Dissecting the causal links between gut microbiome, immune traits and polyp using genetic evidence
Zhou C, Ye X, Liu Z, Liu T, Li S, Yang J, Wei J, Yu P, Jia R, Zhao W |
Frontiers in Immunology | 2024 |
Integrating immunotherapy with conventional treatment regime for breast cancer patients- an amalgamation of armamentarium
Nandi D, Sharma D |
Frontiers in Immunology | 2024 |
Understanding the relationship between breast cancer, immune checkpoint inhibitors, and gut microbiota: a narrative review
Hrubesz G, Leigh J, Ng TL |
Translational Breast Cancer Research | 2024 |
Therapeutic potential of Parabacteroides distasonis in gastrointestinal and hepatic disease
Duan J, Li Q, Cheng Y, Zhu W, Liu H, Li F |
MedComm | 2024 |
Microbiota and Cytokine Modulation: Innovations in Enhancing Anticancer Immunity and Personalized Cancer Therapies
Farhadi Rad H, Tahmasebi H, Javani S, Hemati M, Zakerhamidi D, Hosseini M, Alibabaei F, Banihashemian SZ, Oksenych V, Eslami M |
Biomedicines | 2024 |
Gut–brain axis and brain health: modulating neuroinflammation, cognitive decline, and neurodegeneration
Trisal A, Singh I, Garg G, Jorwal K, Singh AK |
3 Biotech | 2024 |
Colorectal cancer and microbiota: systematic review
Imanbayev N, Iztleuov Y, Bekmukhambetov Y, Abdelazim IA, Donayeva A, Amanzholkyzy A, Aigul Z, Aigerim I, Aslan Y |
Przegla̜d Gastroenterologiczny | 2024 |
The intestinal microbiota and cellular therapy: implications for impact and mechanisms
Xie J, Smith M |
Blood | 2024 |
Hedgehog activity regulates a metabolic program of Treg to Th17 conversion in breast cancer
Dominique Hinshaw, Gloria Benavides, Brandon Metge, Courtney Swain, Sarah Kammerud, Heba Alsheikh, Amr Elhamamsy, Dongquan Chen, Victor Darley-Usmar, Jeffrey Rathmell, Robert Welner, Rajeev Samant, Lalita Shevde |
Cancer immunology research | 2023 |
Gut Microbiota and Breast Cancer: The Dual Role of Microbes
Álvarez-Mercado AI, del Valle Cano A, Fernández MF, Fontana L |
Cancers | 2023 |
Do proton pump inhibitors alter the response to immune checkpoint inhibitors in cancer patients? A meta-analysis
Lopes S, Pabst L, Dory A, Klotz M, Gourieux B, Michel B, Mascaux C |
Frontiers in immunology | 2023 |
CAR-T Cell Therapy and the Gut Microbiota
Asokan S, Cullin N, Stein-Thoeringer CK, Elinav E |
Cancers | 2023 |
Potential links between the microbiota and T cell immunity determine the tumor cell fate
Mohseni AH, Taghinezhad-S S, Casolaro V, Lv Z, Li D |
Cell Death and Disease | 2023 |
The role of the sex hormone-gut microbiome axis in tumor immunotherapy
Wang L, Tang L, Zhai D, Song M, Li W, Xu S, Jiang S, Meng H, Liang J, Wang Y, Zhang B |
Gut microbes | 2023 |
The Interaction between Gut Microbiota and Host Amino Acids Metabolism in Multiple Myeloma
Yang Q, Wei Y, Zhu Y, Guo J, Zhang J, He Y, Li X, Liu J, Zhou W |
Cancers | 2023 |
Diet-gut microbial interactions influence cancer immunotherapy.
Wang X, Geng S |
Frontiers in Oncology | 2023 |
Prognostic and Predictive Biomarkers in the Era of Immunotherapy for Lung Cancer
Pabst L, Lopes S, Bertrand B, Creusot Q, Kotovskaya M, Pencreach E, Beau-Faller M, Mascaux C |
International journal of molecular sciences | 2023 |
A narrative review from gut to lungs: non-small cell lung cancer and the gastrointestinal microbiome
Shah H, Ng TL |
Translational Lung Cancer Research | 2023 |
Gut microbiome homeostasis and the future of probiotics in cancer immunotherapy.
Singh A, Alexander SG, Martin S |
Frontiers in immunology | 2023 |
Neoantigen-specific stem cell memory-like CD4(+) T cells mediate CD8(+) T cell-dependent immunotherapy of MHC class II-negative solid tumors.
Brightman SE, Becker A, Thota RR, Naradikian MS, Chihab L, Zavala KS, Griswold RQ, Dolina JS, Cohen EEW, Miller AM, Peters B, Schoenberger SP |
Nature Immunology | 2023 |
Enhancing therapeutic effects of murine cancer vaccine by reshaping gut microbiota with Lactobacillus rhamnosus GG and jujube powder.
Jing N, Wang L, Zhuang H, Jiang G, Liu Z |
Frontiers in immunology | 2023 |
Liver in infections: a single-cell and spatial transcriptomics perspective
Zou J, Li J, Zhong X, Tang D, Fan X, Chen R |
Journal of biomedical science | 2023 |
Gut and urinary microbiota: the causes and potential treatment measures of renal cell carcinoma
Yang JW, Wan S, Li KP, Chen SY, Yang L |
Frontiers in immunology | 2023 |
How Can the Microbiome Induce Carcinogenesis and Modulate Drug Resistance in Cancer Therapy?
Mendes I, Vale N |
International journal of molecular sciences | 2023 |
Yeast culture supplementation of sow diets regulates the immune performance of their weaned piglets under lipopolysaccharide stress
Liu Y, Jia X, Chang J, Pan X, Jiang X, Che L, Lin Y, Zhuo Y, Feng B, Fang Z, Li J, Hua L, Wang J, Sun M, Wu D, Xu S |
Journal of animal science | 2023 |
The role of the symbiotic microecosystem in cancer: gut microbiota, metabolome, and host immunome
Xue X, Li R, Chen Z, Li G, Liu B, Guo S, Yue Q, Yang S, Xie L, Zhang Y, Zhao J, Tan R |
Frontiers in immunology | 2023 |
Learning from the microbes: exploiting the microbiome to enforce T cell immunotherapy
Staudt S, Ziegler-Martin K, Visekruna A, Slingerland J, Shouval R, Hudecek M, van den Brink M, Luu M |
Frontiers in immunology | 2023 |
T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome.
Klebanoff CA, Chandran SS, Baker BM, Quezada SA, Ribas A |
Nature reviews. Drug discovery | 2023 |
Microbiota in cancer: molecular mechanisms and therapeutic interventions
Chen Z, Guan D, Wang Z, Li X, Dong S, Huang J, Zhou W |
2023 | |
Gut Microbiota, Inflammatory Bowel Disease, and Cancer: The Role of Guardians of Innate Immunity
Giambra V, Pagliari D, Rio P, Totti B, Di Nunzio C, Bosi A, Giaroni C, Gasbarrini A, Gambassi G, Cianci R |
Cells | 2023 |
Association of Age-Related Macular Degeneration with a Blood Biomarker of Lipopolysaccharide, a Gut Bacterial Proinflammatory Toxin.
Larsen PP, Féart C, Pais de Barros JP, Merle BMJ, Gayraud L, Delyfer MN, Korobelnik JF, Delcourt C |
Investigative ophthalmology & visual science | 2023 |
Microbiota: A key factor affecting and regulating the efficacy of immunotherapy
Jiang Y, Jia D, Sun Y, Ding N, Wang L |
Clinical and Translational Medicine | 2023 |
Lymphodepletion – an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle
Lickefett B, Chu L, Ortiz-Maldonado V, Warmuth L, Barba P, Doglio M, Henderson D, Hudecek M, Kremer A, Markman J, Nauerth M, Negre H, Sanges C, Staber PB, Tanzi R, Delgado J, Busch DH, Kuball J, Luu M, Jäger U |
Frontiers in immunology | 2023 |
Melanoma and microbiota: Current understanding and future directions
Routy B, Jackson T, Mählmann L, Baumgartner CK, Blaser M, Byrd A, Corvaia N, Couts K, Davar D, Derosa L, Hang HC, Hospers G, Isaksen M, Kroemer G, Malard F, McCoy KD, Meisel M, Pal S, Ronai Z, Segal E, Sepich-Poore GD, Shaikh F, Sweis RF, Trinchieri G, van den Brink M, Weersma RK, Whiteson K, Zhao L, McQuade J, Zarour H, Zitvogel L |
Cancer Cell | 2023 |
How do tumours outside the gastrointestinal tract respond to dietary fibre supplementation?
Asim F, Clarke L, Donnelly E, Jamal FR, Piccicacchi LM, Qadir M, Raja NT, Samadi C, Then CK, Kiltie AE |
BMJ Oncology | 2023 |
Bidirectional effects of intestinal microbiota and antibiotics: a new strategy for colorectal cancer treatment and prevention
W Zhang, J Zhang, T Liu, J Xing, H Zhang, D Wang, D Tang |
Journal of Cancer Research and Clinical Oncology | 2022 |
B cells imprint adoptively transferred CD8 + T cells with enhanced tumor immunity
A Smith, H Knochelmann, M Wyatt, G Rivera, A Rivera-Reyes, C Dwyer, M Ware, A Cole, D Neskey, M Rubinstein, B Liu, J Thaxton, E Bartee, C Paulos |
Journal for ImmunoTherapy of Cancer | 2022 |
The Microbiome: the Link to Colorectal Cancer and Research Opportunities
S Cass, N Ajami, M White |
Current Treatment Options in Oncology | 2022 |
Host-microbe interactions and outcomes in multiple myeloma and hematopoietic stem cell transplantation
M Pianko, J Golob |
Cancer and Metastasis Reviews | 2022 |
Role-Playing Between Environmental Pollutants and Human Gut Microbiota: A Complex Bidirectional Interaction.
Giambò F, Costa C, Teodoro M, Fenga C |
Frontiers in Medicine | 2022 |
Novel directions of precision oncology: circulating microbial DNA emerging in cancer-microbiome areas
You L, Zhou J, Xin Z, Hauck JS, Na F, Tang J, Zhou X, Lei Z, Ying B |
2022 | |
Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies
Lu Y, Yuan X, Wang M, He Z, Li H, Wang J, Li Q |
Journal of Hematology & Oncology | 2022 |
Emerging role of human microbiome in cancer development and response to therapy: special focus on intestinal microflora
Sadrekarimi H, Gardanova ZR, Bakhshesh M, Ebrahimzadeh F, Yaseri AF, Thangavelu L, Hasanpoor Z, Zadeh FA, Kahrizi MS |
Journal of Translational Medicine | 2022 |
Molecular mimicry between tumor associated antigens and microbiota-derived epitopes
Ragone C, Manolio C, Mauriello A, Cavalluzzo B, Buonaguro FM, Tornesello ML, Tagliamonte M, Buonaguro L |
Journal of Translational Medicine | 2022 |
Gut microbiome in modulating immune checkpoint inhibitors
Li X, Zhang S, Guo G, Han J, Yu J |
EBioMedicine | 2022 |
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab
Martini G, Ciardiello D, Dallio M, Famiglietti V, Esposito L, Corte CM, Napolitano S, Fasano M, Gravina AG, Romano M, Loguercio C, Federico A, Maiello E, Tuccillo C, Morgillo F, Troiani T, Di Maio M, Martinelli E, Ciardiello F |
International Journal of Cancer | 2022 |
Polyphenol Mechanisms against Gastric Cancer and Their Interactions with Gut Microbiota: A Review
Li M, Zheng Y, Zhao J, Liu M, Shu X, Li Q, Wang Y, Zhou Y |
Current Oncology | 2022 |
Targeting the gut microbiota for cancer therapy.
Fernandes MR, Aggarwal P, Costa RGF, Cole AM, Trinchieri G |
Nature reviews. Cancer | 2022 |
Polyphenols: a route from bioavailability to bioactivity addressing potential health benefits to tackle human chronic diseases.
Vivarelli S, Costa C, Teodoro M, Giambò F, Tsatsakis AM, Fenga C |
Archives of Toxicology | 2022 |
Anti-cancer activity of human gastrointestinal bacteria.
Quazi S |
Medical Oncology | 2022 |
Gut Microbiota and Tumor Immune Escape: A New Perspective for Improving Tumor Immunotherapy
He Y, Huang J, Li Q, Xia W, Zhang C, Liu Z, Xiao J, Yi Z, Deng H, Xiao Z, Hu J, Li H, Zu X, Quan C, Chen J |
Cancers | 2022 |
The gut microbiota modulates responses to anti-PD-1 and chemotherapy combination therapy and related adverse events in patients with advanced solid tumors.
Wu Z, Zhang S, Li L, Huang Z, Huang D, Hu Y |
Frontiers in Oncology | 2022 |
The impact of the microbiome in cancer: Targeting metabolism of cancer cells and host.
Huang JT, Mao YQ |
Frontiers in Oncology | 2022 |
Gut microbiota diversity and composition in predicting immunotherapy response and immunotherapy-related colitis in melanoma patients: A systematic review
Oey O, Liu YY, Sunjaya AF, Simadibrata DM, Khattak MA, Gray E |
World journal of clinical oncology | 2022 |
The Microbiome-Immune Axis Therapeutic Effects in Cancer Treatments
Son YM, Kim J |
Journal of Microbiology and Biotechnology | 2022 |
Gut microbiome in multiple myeloma: Mechanisms of progression and clinical applications
Zhang L, Xiang Y, Li Y, Zhang J |
Frontiers in immunology | 2022 |
Attempting to Identify Bacterial Allies in Immunotherapy of NSCLC Patients
Grenda A, Iwan E, Krawczyk P, Frąk M, Chmielewska I, Bomba A, Giza A, Rolska-Kopińska A, Szczyrek M, Kieszko R, Kucharczyk T, Jarosz B, Wasyl D, Milanowski J |
Cancers | 2022 |
Hallmarks of Resistance to Immune-Checkpoint Inhibitors
Karasarides M, Cogdill AP, Robbins PB, Bowden M, Burton EM, Butterfield LH, Cesano A, Hammer C, Haymaker CL, Horak CE, McGee HM, Monette A, Rudqvist NP, Spencer CN, Sweis RF, Vincent BG, Wennerberg E, Yuan J, Zappasodi R, Lucey VM, Wells DK, LaVallee T |
Cancer immunology research | 2022 |
Facts and Hopes for Gut Microbiota Interventions in Cancer Immunotherapy.
Davar D, Zarour HM |
Clinical cancer research | 2022 |
New Insights into the Relationship between Gut Microbiota and Radiotherapy for Cancer
Li Z, Ke X, Zuo D, Wang Z, Fang F, Li B |
Nutrients | 2022 |
Perturbation of the Gut Microbiome and Association with Outcomes Following Autologous Stem Cell Transplantation in Patients with Multiple Myeloma
D\u2019Angelo C, Sudakaran S, Asimakopoulos F, Hematti P, El-Gamal D, Safdar N, Callander N |
Leukemia & Lymphoma | 2022 |
Microbiome as an immune regulator in health, disease, and therapeutics.
Juarez VM, Montalbine AN, Singh A |
Advanced Drug Delivery Reviews | 2022 |
Strategies to Overcome Failures in T-Cell Immunotherapies by Targeting PI3K-δ and –γ
S Chandrasekaran, CR Funk, T Kleber, CM Paulos, M Shanmugam, EK Waller |
Frontiers in immunology | 2021 |
The Role of Gut Microbiota in Overcoming Resistance to Checkpoint Inhibitors in Cancer Patients: Mechanisms and Challenges
Y Bouferraa, A Chedid, G Amhaz, AE Lakkiss, D Mukherji, S Temraz, A Shamseddine |
International journal of molecular sciences | 2021 |
The emerging roles of the gut microbiome in allogeneic hematopoietic stem cell transplantation
LT Khuat, M Dave, WJ Murphy |
Gut microbes | 2021 |
The Microbiome and Its Implications in Cancer Immunotherapy
H Choudhry |
Molecules (Basel, Switzerland) | 2021 |
The Potential Role of the Intestinal Micromilieu and Individual Microbes in the Immunobiology of Chimeric Antigen Receptor T-Cell Therapy
ML Schubert, R Rohrbach, M Schmitt, CK Stein-Thoeringer |
Frontiers in immunology | 2021 |
An oral cancer vaccine using a Bifidobacterium vector suppresses tumor growth in a syngeneic mouse bladder cancer model
K Kitagawa, M Tatsumi, M Kato, S Komai, H Doi, Y Hashii, T Katayama, M Fujisawa, T Shirakawa |
Molecular Therapy — Oncolytics | 2021 |
T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours
S Lesch, V Blumenberg, S Stoiber, A Gottschlich, J Ogonek, BL Cadilha, Z Dantes, F Rataj, K Dorman, J Lutz, CH Karches, C Heise, M Kurzay, BM Larimer, S Grassmann, M Rapp, A Nottebrock, S Kruger, N Tokarew, P Metzger, C Hoerth, MR Benmebarek, D Dhoqina, R Grünmeier, M Seifert, A Oener, Ö Umut, S Joaquina, L Vimeux, T Tran, T Hank, T Baba, D Huynh, RT Megens, KP Janssen, M Jastroch, D Lamp, S Ruehland, MD Pilato, JN Pruessmann, M Thomas, C Marr, S Ormanns, A Reischer, M Hristov, E Tartour, E Donnadieu, S Rothenfusser, P Duewell, LM König, M Schnurr, M Subklewe, AS Liss, N Halama, M Reichert, TR Mempel, S Endres, S Kobold |
Nature Biomedical Engineering | 2021 |
Cell Therapy With TILs: Training and Taming T Cells to Fight Cancer
A Kumar, R Watkins, AE Vilgelm |
Frontiers in immunology | 2021 |
New Insights Into the Cancer–Microbiome–Immune Axis: Decrypting a Decade of Discoveries
T Jain, P Sharma, AC Are, SM Vickers, V Dudeja |
Frontiers in immunology | 2021 |
The microbiome and human cancer
GD Sepich-Poore, L Zitvogel, R Straussman, J Hasty, JA Wargo, R Knight |
Science | 2021 |
Gut Microbiota-Mediated Modulation of Cancer Progression and Therapy Efficacy
P Cheng, P Shen, Y Shan, Y Yang, R Deng, W Chen, Y Lu, Z Wei |
Frontiers in Cell and Developmental Biology | 2021 |
Acute Radiation Syndrome and the Microbiome: Impact and Review
BA Hollingsworth, DR Cassatt, AL DiCarlo, CI Rios, MM Satyamitra, TA Winters, LP Taliaferro |
Frontiers in pharmacology | 2021 |
Toll Like Receptors as Sensors of the Tumor Microbial Dysbiosis: Implications in Cancer Progression
VL Noci, G Bernardo, F Bianchi, E Tagliabue, M Sommariva, L Sfondrini |
Frontiers in Cell and Developmental Biology | 2021 |
Gut microbiota: impacts on gastrointestinal cancer immunotherapy
HC Lau, JJ Sung, J Yu |
Gut microbes | 2021 |
Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study
N Khan, S Lindner, AL Gomes, SM Devlin, GL Shah, AD Sung, CS Sauter, HJ Landau, PB Dahi, MA Perales, DJ Chung, AM Lesokhin, A Dai, A Clurman, JB Slingerland, AE Slingerland, DG Brereton, PA Giardina, M Maloy, GK Armijo, C Rondon-Clavo, E Fontana, L Bohannon, S Ramalingam, AT Bush, MV Lew, JA Messina, E Littmann, Y Taur, RR Jenq, NJ Chao, S Giralt, KA Markey, EG Pamer, MR van den Brink, JU Peled |
Blood | 2021 |
Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment
KC Lam, RE Araya, A Huang, Q Chen, MD Modica, RR Rodrigues, A Lopès, SB Johnson, B Schwarz, E Bohrnsen, AP Cogdill, CM Bosio, JA Wargo, MP Lee, RS Goldszmid |
Cell | 2021 |
Increase in Akkermansiaceae in Gut Microbiota of Prostate Cancer-Bearing Mice
PY Huang, YC Yang, CI Wang, PW Hsiao, HI Chiang, TW Chen |
International journal of molecular sciences | 2021 |
Tying Small Changes to Large Outcomes: The Cautious Promise in Incorporating the Microbiome into Immunotherapy
J Chau, J Zhang |
International journal of molecular sciences | 2021 |
Melatonin and Cancer: A Polyhedral Network Where the Source Matters
MA Bonmati-Carrion, A Tomas-Loba |
Antioxidants | 2021 |
Antitumor efficacy of a neoantigen cancer vaccine delivered by electroporation is influenced by microbiota composition
L Lione, E Salvatori, A Petrazzuolo, A Massacci, R Maggio, A Conforti, M Compagnone, L Aurisicchio, G Ciliberto, F Palombo |
OncoImmunology | 2021 |
Cancer and the Microbiome—Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy
V Matson, CS Chervin, TF Gajewski |
Gastroenterology | 2021 |
Blood microbiota diversity determines response of advanced colorectal cancer to chemotherapy combined with adoptive T cell immunotherapy
D Yang, X Wang, X Zhou, J Zhao, H Yang, S Wang, MA Morse, J Wu, Y Yuan, S Li, A Hobeika, HK Lyerly, J Ren |
OncoImmunology | 2021 |
The Role of Microbiota in Gastrointestinal Cancer and Cancer Treatment – Chance or Curse?
A Smet, J Kupcinskas, A Link, G Hold, J Bornschein |
CMGH Cellular and Molecular Gastroenterology and Hepatology | 2021 |
Bacterial Diversity Correlates with Overall Survival in Cancers of the Head and Neck, Liver, and Stomach.
Rodriguez RM, Menor M, Hernandez BY, Deng Y, Khadka VS |
Molecules (Basel, Switzerland) | 2021 |
Tumor-Associated Microbiome: Where Do We Stand?
Oliva M, Mulet-Margalef N, Ochoa-De-Olza M, Napoli S, Mas J, Laquente B, Alemany L, Duell EJ, Nuciforo P, Moreno V |
International journal of molecular sciences | 2021 |
Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer
Chau J, Yadav M, Liu B, Furqan M, Dai Q, Shahi S, Gupta A, Mercer KN, Eastman E, Hejleh TA, Chan C, Weiner GJ, Cherwin C, Lee ST, Zhong C, Mangalam A, Zhang J |
BMC Cancer | 2021 |
Mechanisms of Aminoglycoside- and Cisplatin-Induced Ototoxicity
Steyger PS |
American Journal of Audiology | 2021 |
The role of a mechanistic host in maintaining arctic rabies variant distributions: Assessment of functional genetic diversity in Alaskan red fox (Vulpes vulpes).
Baecklund TM, Morrison J, Donaldson ME, Hueffer K, Kyle CJ |
PloS one | 2021 |
Machine Learning as a Tool in Investigating the Possible Role of Microbiome in Development and Treatment of Cancer
Hajeebu S, Ngembus NJ, Bandi PS, Panigrahy PK, Heindl S |
Cureus | 2021 |
Gastrointestinal cancers: the role of microbiota in carcinogenesis and the role of probiotics and microbiota in anti-cancer therapy efficacy.
Kaźmierczak-Siedlecka K, Ruszkowski J, Skonieczna-Żydecka K, Jędrzejczak J, Folwarski M, Makarewicz W |
2021 | |
The Emerging Role of the Gut Microbiome in the Cancer Response to Immune Checkpoint Inhibitors: A Narrative Review
Araji G, Maamari J, Ahmad FA, Zareef R, Chaftari P, Yeung SC |
2021 | |
IL6 Fuels Durable Memory for Th17 Cell–Mediated Responses to Tumors
HM Knochelmann, CJ Dwyer, AS Smith, JS Bowers, MM Wyatt, MH Nelson, GO Rivera, JD Horton, C Krieg, K Armeson, GB Lesinski, MP Rubinstein, Z Li, CM Paulos |
Cancer research | 2020 |
Reactive Myelopoiesis and the Onset of Myeloid-Mediated Immune Suppression: Implications for Adoptive Cell Therapy
P Innamarato, S Pilon-Thomas |
Cellular Immunology | 2020 |
Targeting the 4-1BB costimulatory molecule through single chain antibodies promotes the human T-cell response
S Bagheri, ES Qamsari, M Yousefi, F Riazi-Rad, Z Sharifzadeh |
Cellular & Molecular Biology Letters | 2020 |
Microbiome dysbiosis in lung cancer: from composition to therapy
NN Liu, Q Ma, Y Ge, CX Yi, LQ Wei, JC Tan, Q Chu, JQ Li, P Zhang, H Wang |
npj Precision Oncology | 2020 |
Bidirectional interaction between intestinal microbiome and cancer: opportunities for therapeutic interventions
D Dutta, SH Lim |
Biomarker Research | 2020 |
Circulation of gut-preactivated naïve CD8 + T cells enhances antitumor immunity in B cell-defective mice
M Akrami, R Menzies, K Chamoto, M Miyajima, R Suzuki, H Sato, A Nishii, M Tomura, S Fagarasan, T Honjo |
Proceedings of the National Academy of Sciences | 2020 |
Postbiotic-Enabled Targeting of the Host-Microbiota-Pathogen Interface: Hints of Antibiotic Decline?
M Puccetti, S Xiroudaki, M Ricci, S Giovagnoli |
Pharmaceutics | 2020 |
Gut microbiota: a new player in regulating immune- and chemo-therapy efficacy
S Anfossi, GA Calin |
2020 | |
Traditional Chinese Medicine and Gut Microbiome: Their Respective and Concert Effects on Healthcare
R Zhang, , H Bai, K Ning |
Frontiers in pharmacology | 2020 |
Microbes and Cancer: Friends or Faux?
MM Azevedo, C Pina-Vaz, F Baltazar |
International journal of molecular sciences | 2020 |
Challenges in Combining Immunotherapy with Radiotherapy in Recurrent/Metastatic Head and Neck Cancer
G Plavc, T Jesenko, M Oražem, P Strojan |
Cancers | 2020 |
The liver as an immunological barrier redefined by single‐cell analysis
Z Stamataki, L Swadling |
Immunology | 2020 |
The human gastrointestinal microbiota and prostate cancer development and treatment
S Sha, L Ni, M Stefil, M Dixon, V Mouraviev |
Investigative and Clinical Urology | 2020 |
Resveratrol and the Interaction between Gut Microbiota and Arterial Remodelling
AW Man, H Li, N Xia |
Nutrients | 2020 |
Human Tumor-Infiltrating MAIT Cells Display Hallmarks of Bacterial Antigen Recognition in Colorectal Cancer
S Li, Y Simoni, E Becht, CY Loh, N Li, D Lachance, SL Koo, TP Lim, EK Tan, R Mathew, A Nguyen, J Golovato, JD Berkson, M Prlic, B Lee, SS Minot, N Nagarajan, N Dey, DS Tan, IB Tan, EW Newell |
Reproduction | 2020 |
The landscape of bacterial presence in tumor and adjacent normal tissue across 9 major cancer types using TCGA exome sequencing
RM Rodriguez, BY Hernandez, M Menor, Y Deng, VS Khadka |
Computational and Structural Biotechnology Journal | 2020 |
Probiotics Can Boost the Antitumor Immunity of CD8 + T Cells in BALB/c Mice and Patients with Colorectal Carcinoma
J Mao, SZ Zhang, P Du, ZB Cheng, H Hu, SY Wang |
Journal of Immunology Research | 2020 |
Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma.
Xie C, Duffy AG, Brar G, Fioravanti S, Mabry-Hrones D, Walker M, Bonilla CM, Wood BJ, Citrin DE, Gil Ramirez EM, Escorcia FE, Redd B, Hernandez JM, Davis JL, Gasmi B, Kleiner D, Steinberg SM, Jones JC, Greten TF |
Clinical cancer research | 2020 |
Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway.
Xu X, Lv J, Guo F, Li J, Jia Y, Jiang D, Wang N, Zhang C, Kong L, Liu Y, Zhang Y, Lv J, Li Z |
Frontiers in microbiology | 2020 |
Microbiota in cancer chemoradiotherapy resistance
He Y, Liu QW, Liao HX, Xu WW |
Clinical and Translational Medicine | 2020 |
Association of Chronic Opisthorchis Infestation and Microbiota Alteration on Tumorigenesis in Cholangiocarcinoma
Ketpueak T, Thiennimitr P, Apaijai N, Chattipakorn SC, Chattipakorn N |
Clinical and Translational Gastroenterology | 2020 |
Mechanisms and microbial influences on CTLA-4 and PD-1-based immunotherapy in the treatment of cancer: a narrative review.
Miller PL, Carson TL |
Gut pathogens | 2020 |
Pancreatic Cancer, Gut Microbiota, and Therapeutic Efficacy
Zhang X, Liu Q, Liao Q, Zhao Y |
Journal of Cancer | 2020 |
提高过继性T细胞免疫治疗临床疗效的新思考----肠道菌群与肿瘤免疫
任 军, 杨 朵 |
2020 | |
The Inhibitory Effect of Gut Microbiota and Its Metabolites on Colorectal Cancer
Chen C, Li H |
Journal of Microbiology and Biotechnology | 2020 |
Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced anti-tumor immune response
Mireia Uribe-Herranz, Stavros Rafail, Silvia Beghi, Luis Gil-de-Gómez, Ioannis Verginadis, Kyle Bittinger, Sergey Pustylnikov, Stefano Pierini, Renzo Perales-Linares, Ian A Blair, Clementina Mesaros, Nathaniel W Snyder, Frederic Bushman, Constantinos Koumenis, Andrea Facciabene |
Journal of Clinical Investigation | 2019 |
Developing neoantigen-targeted T cell–based treatments for solid tumors
TN Yamamoto, RJ Kishton, NP Restifo |
Nature Medicine | 2019 |
Biomarkers for Immunotherapy of Cancer: Methods and Protocols
M Thurin, A Cesano, FM Marincola |
2019 | |
Gut microbiome and CAR-T therapy
MB Abid, NN Shah, TC Maatman, PN Hari |
Experimental Hematology and Oncology | 2019 |
Host conditioning with IL-1β improves the antitumor function of adoptively transferred T cells
PH Lee, TN Yamamoto, D Gurusamy, M Sukumar, Z Yu, J Hu-Li, T Kawabe, A Gangaplara, RJ Kishton, AN Henning, SK Vodnala, RN Germain, WE Paul, NP Restifo |
Journal of Experimental Medicine | 2019 |
Redox-responsive interleukin-2 nanogel specifically and safely promotes the proliferation and memory precursor differentiation of tumor-reactive T-cells
YQ Xie, H Arik, L Wei, Y Zheng, H Suh, DJ Irvine, L Tang |
Biomaterials Science | 2019 |
Host tissue determinants of tumour immunity
H Salmon, R Remark, S Gnjatic, M Merad |
Nature Reviews Cancer | 2019 |
Innate lymphoid cells: A potential link between microbiota and immune responses against cancer
SK Panda, M Colonna |
Seminars in Immunology | 2019 |
Gut Microbiota and Cancer: From Pathogenesis to Therapy
S Vivarelli, R Salemi, S Candido, L Falzone, M Santagati, S Stefani, F Torino, G Banna, G Tonini, M Libra |
Cancers | 2019 |
Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis
Q Ma, C Xing, W Long, HY Wang, Q Liu, RF Wang |
Journal of Neuroinflammation | 2019 |
Exploring the emerging role of the microbiome in cancer immunotherapy
J Fessler, V Matson, TF Gajewski |
Journal for ImmunoTherapy of Cancer | 2019 |
The Human Microbiota and Prostate Cancer: Friend or Foe?
F Massari, V Mollica, VD Nunno, L Gatto, M Santoni, M Scarpelli, A Cimadamore, A Lopez-Beltran, L Cheng, N Battelli, R Montironi, G Brandi |
Cancers | 2019 |
Lubiprostone as a potential therapeutic agent to improve intestinal permeability and prevent the development of atherosclerosis in apolipoprotein E-deficient mice
K Arakawa, T Ishigami, M Nakai-Sugiyama, L Chen, H Doi, T Kino, S Minegishi, S Saigoh-Teranaka, R Sasaki-Nakashima, K Hibi, K Kimura, K Tamura, M Bader |
PloS one | 2019 |
Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment?
R Villéger, A Lopès, G Carrier, J Veziant, E Billard, N Barnich, J Gagnière, E Vazeille, M Bonnet |
International journal of molecular sciences | 2019 |
Antitumor T-cell Homeostatic Activation Is Uncoupled from Homeostatic Inhibition by Checkpoint Blockade
N Marshall, K Hutchinson, TU Marron, M Aleynick, L Hammerich, R Upadhyay, J Svensson-Arvelund, BD Brown, M Merad, JD Brody |
Cancer Discovery | 2019 |
Impact of bowel movement condition on immune checkpoint inhibitor efficacy in patients with advanced non-small cell lung cancer.
Katayama Y, Yamada T, Tanimura K, Yoshimura A, Takeda T, Chihara Y, Tamiya N, Kaneko Y, Uchino J, Takayama K |
Thoracic Cancer | 2019 |
Impact of the microbiome on cancer progression and response to anti-cancer therapies
Buchta Rosean C, Feng TY, Azar FN, Rutkowski MR |
Advances in cancer research | 2019 |
Therapeutic effects of iNOS inhibition against vitiligo in an animal model.
Mansourpour H, Ziari K, Motamedi SK, Poor AH |
European Journal of Translational Myology | 2019 |
Antibiotic therapy and outcome from immune-checkpoint inhibitors
Pinato DJ, Gramenitskaya D, Altmann DM, Boyton RJ, Mullish BH, Marchesi JR, Bower M |
Journal for ImmunoTherapy of Cancer | 2019 |
Gut microbiota modulates adoptive cell therapy via CD8α dendritic cells and IL-12
Mireia Uribe-Herranz, Kyle Bittinger, Stavros Rafail, Sonia Guedan, Stefano Pierini, Ceylan Tanes, Alex Ganetsky, Mark A Morgan, Saar Gill, Janos L. Tanyi, Frederic Bushman, Carl June, Andrea Facciabene |
JCI Insight | 2018 |
The Pharmacology of T Cell Therapies
MC Milone, VG Bhoj |
Molecular Therapy — Methods & Clinical Development | 2018 |
IL-2 and Beyond in Cancer Immunotherapy
JM Wrangle, A Patterson, CB Johnson, DJ Neitzke, S Mehrotra, CE Denlinger, CM Paulos, Z Li, DJ Cole, MP Rubinstein |
Journal of Interferon & Cytokine Research | 2018 |
Radiation effects on antitumor immune responses: current perspectives and challenges
T Walle, RM Monge, A Cerwenka, D Ajona, I Melero, F Lecanda |
Therapeutic advances in medical oncology | 2018 |
Combined sublethal irradiation and agonist anti-CD40 enhance donor T cell accumulation and control of autochthonous murine pancreatic tumors
LK Ward-Kavanagh, KM Kokolus, TK Cooper, AE Lukacher, TD Schell |
Cancer Immunology, Immunotherapy | 2018 |
Gut microbiota injury in allogeneic haematopoietic stem cell transplantation
Y Shono, MR van Brink |
Nature Reviews Cancer | 2018 |
The clinical role of the TME in solid cancer
NA Giraldo, R Sanchez-Salas, JD Peske, Y Vano, E Becht, F Petitprez, P Validire, A Ingels, X Cathelineau, WH Fridman, C Sautès-Fridman |
British Journal of Cancer | 2018 |
Microbial markers in colorectal cancer detection and/or prognosis
R Villéger, A Lopès, J Veziant, J Gagnière, N Barnich, E Billard, D Boucher, M Bonnet |
World journal of gastroenterology : WJG | 2018 |
The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy
V Gopalakrishnan, BA Helmink, CN Spencer, A Reuben, JA Wargo |
Cancer Cell | 2018 |
Gut Microbiome and the Response to Immunotherapy in Cancer.
Stancu AL |
2018 | |
Pharmacologic inhibition of β-catenin and PI3Kδ paradoxically expands precursor Th17 cells with heightened stemness and antitumor activity
Kinga Majchrzak, Michelle H. Nelson, Jacob Bowers, Stefanie Bailey, Megan Meek, John Wrangle, Juan Varela, Mark Rubinstein, zihai Li, Richard Himes, Sherine Chan, Chrystal Paulos |
JCI Insight | 2017 |
Anticancer effects of the microbiome and its products
L Zitvogel, R Daillère, MP Roberti, B Routy, G Kroemer |
Nature Reviews Microbiology | 2017 |
Trial Watch: Adoptively transferred cells for anticancer immunotherapy
C Fournier, F Martin, L Zitvogel, G Kroemer, L Galluzzi, L Apetoh |
OncoImmunology | 2017 |
Systematic evaluation of immune regulation and modulation
DF Stroncek, LH Butterfield, MA Cannarile, MV Dhodapkar, TF Greten, JC Grivel, DR Kaufman, HH Kong, F Korangy, PP Lee, F Marincola, S Rutella, JC Siebert, G Trinchieri, B Seliger |
Journal for ImmunoTherapy of Cancer | 2017 |
The impact of antibiotic usage on the efficacy of chemoimmunotherapy is contingent on the source of tumor-reactive T cells
MP Kuczma, ZC Ding, T Li, T Habtetsion, T Chen, Z Hao, L Bryan, N Singh, JN Kochenderfer, G Zhou |
Oncotarget | 2017 |
Stimulating Innate Immunity to Enhance Radiation Therapy–Induced Tumor Control
JR Baird, AM Monjazeb, O Shah, H McGee, WJ Murphy, MR Crittenden, MJ Gough |
International journal of radiation oncology, biology, physics | 2017 |
Immunotherapy of cancer: targeting cancer during active disease or during dormancy?
SA Shah, M Zarei, SH Manjili, G Guruli, XY Wang, MH Manjili |
Immunotherapy | 2017 |
In Vivo Murine-Matured Human CD3 + Cells as a Preclinical Model for T Cell-Based Immunotherapies
KG Haworth, C Ironside, ZK Norgaard, WM Obenza, JE Adair, HP Kiem |
Molecular Therapy - Methods & Clinical Development | 2017 |
Homeostatic Immunity and the Microbiota
Y Belkaid, OJ Harrison |
Immunity | 2017 |
Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma
KM Hargadon |
Frontiers in immunology | 2017 |
Regulated Expansion and Survival of Chimeric Antigen Receptor-Modified T Cells Using Small Molecule-Dependent Inducible MyD88/CD40
AE Foster, A Mahendravada, NP Shinners, WC Chang, J Crisostomo, A Lu, M Khalil, E Morschl, JL Shaw, S Saha, ML Duong, MR Collinson-Pautz, DL Torres, T Rodriguez, T Pentcheva-Hoang, JH Bayle, KM Slawin, DM Spencer |
Molecular Therapy | 2017 |
The influence of the commensal microbiota on distal tumor-promoting inflammation
CM Rosean, MR Rutkowski |
Seminars in Immunology | 2017 |
Depletion of enteric bacteria diminishes leukocyte infiltration following doxorubicin-induced small intestinal damage in mice
JS Carr, S King, CM Dekaney, SR Singh |
PloS one | 2017 |
Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation
JU Peled, SM Devlin, A Staffas, M Lumish, R Khanin, ER Littmann, L Ling, S Kosuri, M Maloy, JB Slingerland, KF Ahr, KA Rodriguez, Y Shono, AE Slingerland, MD Docampo, AD Sung, D Weber, AM Alousi, B Gyurkocza, DM Ponce, JN Barker, MA Perales, SA Giralt, Y Taur, EG Pamer, RR Jenq, MR van Brink |
Journal of Clinical Oncology | 2017 |
Monitoring neonates for ototoxicity
AC Garinis, A Kemph, AM Tharpe, JH Weitkamp, C McEvoy, PS Steyger |
International Journal of Audiology | 2017 |
Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
V Gopalakrishnan, CN Spencer, L Nezi, A Reuben, MC Andrews, TV Karpinets, PA Prieto, D Vicente, K Hoffman, SC Wei, AP Cogdill, L Zhao, CW Hudgens, DS Hutchinson, T Manzo, MP de Macedo, T Cotechini, T Kumar, WS Chen, SM Reddy, RS Sloane, J Galloway-Pena, H Jiang, PL Chen, EJ Shpall, K Rezvani, AM Alousi, RF Chemaly, S Shelburne, LM Vence, PC Okhuysen, VB Jensen, AG Swennes, F McAllister, EM Sanchez, Y Zhang, EL Chatelier, L Zitvogel, N Pons, JL Austin-Breneman, LE Haydu, EM Burton, JM Gardner, E Sirmans, J Hu, AJ Lazar, T Tsujikawa, A Diab, H Tawbi, IC Glitza, WJ Hwu, SP Patel, SE Woodman, RN Amaria, MA Davies, JE Gershenwald, P Hwu, JE Lee, J Zhang, LM Coussens, ZA Cooper, PA Futreal, CR Daniel, NJ Ajami, JF Petrosino, MT Tetzlaff, P Sharma, JP Allison, RR Jenq, JA Wargo |
Science | 2017 |
Unlocking the Complex Flavors of Dysgeusia after Hematopoietic Cell Transplantation
Scordo M, Shah G, Peled JU, Preston E, Buchan M, Epstein JB, Barasch A, Giralt S |
Biology of Blood and Marrow Transplantation | 2017 |
Origins of cancer: tackling provocative questions
Solitro AR, Vander Schaaf NA |
Genes & cancer | 2017 |
Gut microbiota and immune crosstalk in metabolic disease
R Burcelin |
Molecular Metabolism | 2016 |
Toll-like receptor agonist therapy can profoundly augment the antitumor activity of adoptively transferred CD8+ T cells without host preconditioning
MH Nelson, JS Bowers, SR Bailey, MA Diven, CW Fugle, AD Kaiser, C Wrzesinski, B Liu, NP Restifo, CM Paulos |
Journal for ImmunoTherapy of Cancer | 2016 |
Requirement of interleukin 7 signaling for anti-tumor immune response under lymphopenic conditions in a murine lung carcinoma model
T Suzuki, H Kishimoto, R Abe |
Cancer Immunology, Immunotherapy | 2016 |
Translocation of microbes and changes of immunocytes in the gut of rapid- and slow-progressor Chinese rhesus macaques infected with SIVmac239
LT Zhang, RR Tian, HY Zheng, GQ Pan, XY Tuo, HJ Xia, XS Xia, W Pang, YT Zheng |
Immunology | 2016 |
Adapting Cancer Immunotherapy Models for the Real World
LE Klevorn, RM Teague |
Trends in Immunology | 2016 |
Effect of administration timing of postchemotherapy granulocyte colony-stimulating factor on host-immune cell recovery and CD8 + T-cell response
ML Salem, M Nassef, SG Salam, A Zidan, MH Mahmoud, G Badr, M Rubinstein, D Cole |
Journal of Immunotoxicology | 2016 |
The Impact of Chemotherapy, Radiation and Epigenetic Modifiers in Cancer Cell Expression of Immune Inhibitory and Stimulatory Molecules and Anti-Tumor Efficacy
J Chacon, K Schutsky, D Powell |
Human vaccines | 2016 |
Inflammatory Signals Regulate IL-15 in Response to Lymphodepletion
SM Anthony, SC Rivas, SL Colpitts, ME Howard, SW Stonier, KS Schluns |
Journal of immunology (Baltimore, Md. : 1950) | 2016 |
The Basis of Oncoimmunology
AK Palucka, LM Coussens |
Cell | 2016 |
The role of microbiota in cancer therapy
E Perez-Chanona, G Trinchieri |
Current Opinion in Immunology | 2016 |
Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting
CY Slaney, B von Scheidt, AJ Davenport, PA Beavis, JA Westwood, S Mardiana, DC Tscharke, S Ellis, HM Prince, JA Trapani, RW Johnstone, MJ Smyth, MW Teng, A Ali, Z Yu, SA Rosenberg, NP Restifo, P Neeson, PK Darcy, MH Kershaw |
Clinical cancer research | 2016 |
Microbiota-myeloid cell crosstalk beyond the gut.
Gorjifard S, Goldszmid RS |
Journal of leukocyte biology | 2016 |
T-cell receptor gene therapy - ready to go viral?
T Karpanen, J Olweus |
Molecular Oncology | 2015 |
Rapid Functional Decline of Activated and Memory Graft-versus-Host-Reactive T Cells Encountering Host Antigens in the Absence of Inflammation
HW Li, G Andreola, AL Carlson, S Shao, CP Lin, G Zhao, M Sykes |
Journal of immunology (Baltimore, Md. : 1950) | 2015 |
Intestinal inhibition of Atg7 prevents tumour initiation through a microbiome-influenced immune response and suppresses tumour growth
J Lévy, W Cacheux, MA Bara, A L’Hermitte, P Lepage, M Fraudeau, C Trentesaux, J Lemarchand, A Durand, AM Crain, C Marchiol, G Renault, F Dumont, F Letourneur, M Delacre, A Schmitt, B Terris, C Perret, M Chamaillard, JP Couty, B Romagnolo |
Nature Cell Biology | 2015 |
Dendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 Signaling
JS Bowers, MH Nelson, S Kundimi, SR Bailey, LW Huff, KM Schwartz, DJ Cole, MP Rubinstein, CM Paulos |
Clinical cancer research | 2015 |
Harnessing the Microbiome to Enhance Cancer Immunotherapy
MH Nelson, MA Diven, LW Huff, CM Paulos |
Journal of Immunology Research | 2015 |
Systemic LPS Translocation Activates Cross-Presenting Dendritic Cells but Is Dispensable for the Breakdown of CD8+ T Cell Peripheral Tolerance in Irradiated Mice
G Espinosa-Carrasco, M Villard, CL Saout, P Louis-Plence, R Vicente, J Hernandez, H Shiku |
PloS one | 2015 |
Adoptive cell transfer as personalized immunotherapy for human cancer
SA Rosenberg, NP Restifo |
Science | 2015 |
Genetically modified T cells in cancer therapy: opportunities and challenges
M Sharpe, N Mount |
Disease models & mechanisms | 2015 |
Beyond consolidation: auto-SCT and immunotherapy for plasma cell myeloma
N Lendvai, AD Cohen, HJ Cho |
Bone Marrow Transplantation | 2015 |
Microbiota Modulation of Myeloid Cells in Cancer Therapy
RS Goldszmid, A Dzutsev, S Viaud, L Zitvogel, NP Restifo, G Trinchieri |
Cancer immunology research | 2015 |
Radiation takes its Toll
JA Ratikan, ED Micewicz, MW Xie, D Schaue |
Cancer Letters | 2015 |
The Inducible Costimulator Augments Tc17 Cell Responses to Self and Tumor Tissue
MH Nelson, S Kundimi, JS Bowers, CE Rogers, LW Huff, KM Schwartz, K Thyagarajan, EC Little, S Mehrotra, DJ Cole, MP Rubinstein, CM Paulos |
Journal of immunology (Baltimore, Md. : 1950) | 2015 |
Phorbol ester-induced neutrophilic inflammatory responses selectively promote metastatic spread of melanoma in a TLR4-dependent manner
T Bald, J Landsberg, P Jansen, E Gaffal, T Tüting |
OncoImmunology | 2015 |
Cancer Immunity: Lessons From Infectious Diseases
G Trinchieri |
The Journal of Infectious Diseases | 2015 |
Epithelial-derived IL-18 regulates Th17 cell differentiation and Foxp3+ Treg cell function in the intestine
OJ Harrison, N Srinivasan, J Pott, C Schiering, T Krausgruber, NE Ilott, KJ Maloy |
Mucosal Immunology | 2015 |
Cancer and the gut microbiota: An unexpected link
L Zitvogel, L Galluzzi, S Viaud, M Vetizou, R Daillere, M Merad, G Kroemer |
Science Translational Medicine | 2015 |
SHIPi Enhances Autologous and Allogeneic Hematopoietic Stem Cell Transplantation
S Fernandes, R Brooks, M Gumbleton, MY Park, CM Russo, KT Howard, JD Chisholm, WG Kerr |
EBioMedicine | 2015 |
Depletion of B220 + NK1.1 + cells enhances the rejection of established melanoma by tumor-specific CD4 + T cells
KA Wilson, SR Goding, HR Neely, KM Harris, PA Antony |
OncoImmunology | 2015 |
Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral Immunotherapy
M Blanchard, KG Shim, MP Grams, K Rajani, RM Diaz, KM Furutani, J Thompson, KR Olivier, SS Park, SN Markovic, H Pandha, A Melcher, K Harrington, S Zaidi, R Vile |
International journal of radiation oncology, biology, physics | 2015 |
Toxicities Associated With Adoptive T-Cell Transfer for Cancer:
JC Yang |
The Cancer Journal | 2015 |
Short Course in the Microbiome
K Falana, R Knight, CR Martin, R Goldszmid, KL Greathouse, J Gere, H Young, WP Kuo |
Journal of Circulating Biomarkers | 2015 |
A new hope in immunotherapy for malignant gliomas: adoptive T cell transfer therapy
DS Chung, HJ Shin, YK Hong |
Journal of Immunology Research | 2014 |
Role of the Microbiota in Immunity and Inflammation
Y Belkaid, TW Hand |
Cell | 2014 |
Novel immunotherapies for hematologic malignancies
MH Nelson, CM Paulos |
Immunological Reviews | 2014 |
MART-1 peptide vaccination plus IMP321 (LAG-3Ig fusion protein) in patients receiving autologous PBMCs after lymphodepletion: results of a Phase I trial
E Romano, O Michielin, V Voelter, J Laurent, H Bichat, A Stravodimou, P Romero, DE Speiser, F Triebel, S Leyvraz, A Harari |
Journal of Translational Medicine | 2014 |
Th17 Cells in Cancer: The Ultimate Identity Crisis
SR Bailey, MH Nelson, RA Himes, Z Li, S Mehrotra, CM Paulos |
Frontiers in immunology | 2014 |
Identification of the genomic insertion site of Pmel-1 TCR α and β transgenes by next-generation sequencing
Y Ji, N Abrams, W Zhu, E Salinas, Z Yu, DC Palmer, P Jailwala, Z Franco, R Roychoudhuri, E Stahlberg, L Gattinoni, NP Restifo |
PloS one | 2014 |
Whole-Body Irradiation Increases the Magnitude and Persistence of Adoptively Transferred T Cells Associated with Tumor Regression in a Mouse Model of Prostate Cancer
LK Ward-Kavanagh, J Zhu, TK Cooper, TD Schell |
Cancer immunology research | 2014 |
Radiation as immunomodulator: implications for dendritic cell-based immunotherapy
RE Roses, J Datta, BJ Czerniecki |
Radiation Research | 2014 |
T-Cell Immunotherapy: Looking Forward
J Corrigan-Curay, HP Kiem, D Baltimore, M O'Reilly, RJ Brentjens, L Cooper, S Forman, S Gottschalk, P Greenberg, R Junghans, H Heslop, M Jensen, C Mackall, C June, O Press, D Powell, A Ribas, S Rosenberg, M Sadelain, B Till, AP Patterson, RC Jambou, E Rosenthal, L Gargiulo, M Montgomery, DB Kohn |
Molecular Therapy | 2014 |
miR-155 augments CD8 + T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γ c cytokines
Y Ji, C Wrzesinski, Z Yu, J Hu, S Gautam, NV Hawk, WG Telford, DC Palmer, Z Franco, M Sukumar, R Roychoudhuri, D Clever, CA Klebanoff, CD Surh, TA Waldmann, NP Restifo, L Gattinoni |
2014 | |
Protection from tumor recurrence following adoptive immunotherapy varies with host conditioning regimen despite initial regression of autochthonous murine brain tumors
EM Cozza, TK Cooper, LR Budgeon, ND Christensen, TD Schell |
Cancer Immunology, Immunotherapy | 2014 |
Host Immune Response to Infection and Cancer: Unexpected Commonalities
RS Goldszmid, A Dzutsev, G Trinchieri |
Cell Host & Microbe | 2014 |
Current advances in T-cell-based cancer immunotherapy
M Wang, B Yin, HY Wang, RF Wang |
Immunotherapy | 2014 |
Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy
SC Wagner, B Markosian, N Ajili, BR Dolan, AJ Kim, DT Alexandrescu, CA Dasanu, B Minev, J Koropatnick, FM Marincola, NH Riordan |
Journal of Translational Medicine | 2014 |
Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions
M Piesche, VT Ho, H Kim, Y Nakazaki, M Nehil, NK Yaghi, D Kolodin, J Weiser, P Altevogt, H Kiefel, EP Alyea, JH Antin, C Cutler, J Koreth, C Canning, J Ritz, RJ Soiffer, G Dranoff |
Clinical cancer research | 2014 |
Harnessing the Intestinal Microbiome for Optimal Therapeutic Immunomodulation
S Viaud, R Daillere, IG Boneca, P Lepage, MJ Pittet, F Ghiringhelli, G Trinchieri, R Goldszmid, L Zitvogel |
Cancer research | 2014 |
Retinoic acid controls the homeostasis of pre-cDC-derived splenic and intestinal dendritic cells
CA Klebanoff, SP Spencer, P Torabi-Parizi, JR Grainger, R Roychoudhuri, Y Ji, M Sukumar, P Muranski, CD Scott, JA Hall, GA Ferreyra, AJ Leonardi, ZA Borman, J Wang, DC Palmer, C Wilhelm, R Cai, J Sun, JL Napoli, RL Danner, L Gattinoni, Y Belkaid, NP Restifo |
Journal of Experimental Medicine | 2013 |
EGFRvIII mCAR-Modified T-Cell Therapy Cures Mice with Established Intracerebral Glioma and Generates Host Immunity against Tumor-Antigen Loss
JH Sampson, BD Choi, L Sanchez-Perez, CM Suryadevara, DJ Snyder, CT Flores, RJ Schmittling, SK Nair, EA Reap, PK Norberg, JE Herndon, CT Kuan, RA Morgan, SA Rosenberg, LA Johnson |
Clinical cancer research | 2013 |
Exploiting the curative potential of adoptive T-cell therapy for cancer
CS Hinrichs, SA Rosenberg |
Immunological Reviews | 2013 |
Reassessing target antigens for adoptive T-cell therapy
CS Hinrichs, NP Restifo |
Nature Biotechnology | 2013 |
Characterization of direct radiation-induced immune function and molecular signaling changes in an antigen presenting cell line
JJ Parker, JC Jones, S Strober, SJ Knox |
Clinical Immunology | 2013 |
Immune surveillance by the liver
CN Jenne, P Kubes |
Nature Immunology | 2013 |
A critical role of toll-like receptor 4 (TLR4) and its' in vivo ligands in basal radio-resistance
C Liu, C Zhang, RE Mitchel, J Cui, J Lin, Y Yang, X Liu, J Cai |
Cell Death and Disease | 2013 |
Adoptive T-cell transfer combined with a single low dose of total body irradiation eradicates breast tumors
NM Lerret, AL Marzo |
OncoImmunology | 2013 |
Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
N Iida, A Dzutsev, CA Stewart, L Smith, N Bouladoux, RA Weingarten, DA Molina, R Salcedo, T Back, S Cramer, RM Dai, H Kiu, M Cardone, S Naik, AK Patri, E Wang, FM Marincola, KM Frank, Y Belkaid, G Trinchieri, RS Goldszmid |
Science | 2013 |
Polyarginine Induces an Antitumor Immune Response through Binding to Toll-Like Receptor 4
Y Yang, J Wolfram, X Fang, H Shen, M Ferrari |
Small | 2013 |
The Past, Present, and Future of Adoptive T Cell Therapy
D Choi, TG Kim, YC Sung |
Immune Network | 2012 |
Adoptive Transfer of Mammaglobin-A Epitope Specific CD8 T Cells Combined with a Single Low Dose of Total Body Irradiation Eradicates Breast Tumors
NM Lerret, M Rogozinska, A Jaramillo, AL Marzo |
PloS one | 2012 |
Adoptive Immunotherapy of Advanced Melanoma
R Shapira-Frommer, J Schachter |
Current Treatment Options in Oncology | 2012 |
The Future Is Now: Chimeric Antigen Receptors as New Targeted Therapies for Childhood Cancer
DW Lee, DM Barrett, C Mackall, R Orentas, SA Grupp |
Clinical cancer research | 2012 |
Adoptive immunotherapy for cancer: harnessing the T cell response
NP Restifo, ME Dudley, SA Rosenberg |
Nature Reviews Immunology | 2012 |
The role of innate immune signals in antitumor immunity
M Jinushi |
OncoImmunology | 2012 |
Tumor-Infiltrating Lymphocytes in Melanoma
S Lee, K Margolin |
Current Oncology Reports | 2012 |
Emerging concepts in haematopoietic cell transplantation
HW Li, M Sykes |
Nature Reviews Immunology | 2012 |
Adoptive Transfer of Cytotoxic T Lymphocytes Targeting Two Different Antigens Limits Antigen Loss and Tumor Escape
KM Kaluza, T Kottke, RM Diaz, D Rommelfanger, J Thompson, R Vile |
Human Gene Therapy | 2012 |
Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
HJ Pegram, JC Lee, EG Hayman, GH Imperato, TF Tedder, M Sadelain, RJ Brentjens |
Blood | 2012 |
Human Tumor Xenografts: The Good, the Bad, and the Ugly
RA Morgan |
Molecular Therapy | 2012 |
An Improved Protocol for Efficient Engraftment in NOD/LTSZ-SCIDIL-2RγNULL Mice Allows HIV Replication and Development of Anti-HIV Immune Responses
M Singh, P Singh, G Gaudray, L Musumeci, C Thielen, D Vaira, C Vandergeeten, L Delacroix, EV Gulck, G Vanham, L Leval, S Rahmouni, M Moutschen |
PloS one | 2012 |
Donor bone marrow-derived T cells inhibit GVHD induced by donor lymphocyte infusion in established mixed allogeneic hematopoietic chimeras
H Wang, Y Yang, G Wang, S Wang, BY Yeap, M Sykes, YG Yang |
PloS one | 2012 |
Effect of solar particle event radiation and hindlimb suspension on gastrointestinal tract bacterial translocation and immune activation
Y Zhou, H Ni, M Li, JK Sanzari, ES Diffenderfer, L Lin, AR Kennedy, D Weissman |
PloS one | 2012 |
A potent vaccination strategy that circumvents lymphodepletion for effective antitumor adoptive T-cell therapy
HI Cho, E Reyes-Vargas, JC Delgado, E Celis |
Cancer research | 2012 |
The Efficacy Versus Toxicity Profile of Combination Virotherapy and TLR Immunotherapy Highlights the Danger of Administering TLR Agonists to Oncolytic Virus-treated Mice
DM Rommelfanger, MC Grau, RM Diaz, E Ilett, L Alvarez-Vallina, JM Thompson, TJ Kottke, A Melcher, RG Vile |
Molecular Therapy | 2012 |
Role of the Toll-like receptor pathway in the recognition of orthopedic implant wear-debris particles
JI Pearl, T Ma, AR Irani, Z Huang, WH Robinson, RL Smith, SB Goodman |
Biomaterials | 2011 |
Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment
J Amar, C Chabo, A Waget, P Klopp, C Vachoux, LG Bermúdez-Humarán, N Smirnova, M Bergé, T Sulpice, S Lahtinen, A Ouwehand, P Langella, N Rautonen, PJ Sansonetti, R Burcelin |
EMBO Molecular Medicine | 2011 |
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
SA Quezada, KS Peggs, TR Simpson, JP Allison |
Immunological Reviews | 2011 |
Toll-Like Receptor 4 Activation in Cancer Progression and Therapy
A Oblak, R Jerala |
Clinical and Developmental Immunology | 2011 |
Cell transfer immunotherapy for metastatic solid cancer—what clinicians need to know
SA Rosenberg |
Nature Reviews Clinical Oncology | 2011 |
Effect of Solar Particle Event Radiation on Gastrointestinal Tract Bacterial Translocation and Immune Activation
H Ni, K Balint, Y Zhou, DS Gridley, C Maks, AR Kennedy, D Weissman |
Radiation Research | 2011 |
Selective Resistance of CD44 hi T Cells to p53-Dependent Cell Death Results in Persistence of Immunologic Memory after Total Body Irradiation
Z Yao, J Jones, H Kohrt, S Strober |
Journal of immunology (Baltimore, Md. : 1950) | 2011 |
New perspectives on the role of vitiligo in immune responses to melanoma.
Byrne KT, Turk MJ |
Oncotarget | 2011 |
Tumor destruction and spontaneous autoimmunity following long-term lentiviral CD4+ TCR gene-modified HSC transplantation in mice
Sung Ha, Nicholas Klemen, Garrett Kinnebrew, Andrew Brandmaier, Jon Marsh, Giao Hangoc, Douglas Palmer, Nicholas Restifo, Ken Cornetta, Hal E. Broxmeyer, Christopher Touloukian |
Journal of Clinical Investigation | 2010 |
Amplifying TLR-MyD88 signals within tumor-specific T-cells enhances antitumor activity to suboptimal levels of weakly-immunogenic tumor-antigens
D Geng, L Zheng, R Srivastava, C Velasco-Gonzalez, A Riker, SN Markovic, E Davila |
Cancer research | 2010 |
Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma
Y Xie, A Akpinarli, C Maris, EL Hipkiss, M Lane, EK Kwon, P Muranski, NP Restifo, PA Antony |
Journal of Experimental Medicine | 2010 |
Therapeutic cancer vaccines: are we there yet?
CA Klebanoff, N Acquavella, Z Yu, NP Restifo |
Immunological Reviews | 2010 |
IL-2 Mediates CD4+ T Cell Help in the Breakdown of Memory-Like CD8+ T Cell Tolerance under Lymphopenic Conditions
CL Saout, M Villard, C Cabasse, C Jacquet, N Taylor, J Hernandez, D Unutmaz |
PloS one | 2010 |
Cyclophosphamide induces bone marrow to yield higher numbers of precursor dendritic cells in vitro capable of functional antigen presentation to T cells in vivo
ML Salem, SA El-Naggar, DJ Cole |
Cellular Immunology | 2010 |
Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T cells
C Wrzesinski, CM Paulos, A Kaiser, P Muranski, DC Palmer, L Gattinoni, Z Yu, SA Rosenberg, NP Restifo |
Journal of immunotherapy (Hagerstown, Md. : 1997) | 2010 |
Intestinal Bacteria and the Regulation of Immune Cell Homeostasis
DA Hill, D Artis |
Annual Review of Immunology | 2010 |
Toll-like receptor agonists: are they good adjuvants?
S Gnjatic, NB Sawhney, N Bhardwaj |
Cancer journal (Sudbury, Mass.) | 2010 |
The role of TLR2, TRL3, TRL4, and TRL9 signaling in the pathogenesis of autoimmune disease in a retinal autoimmunity model
J Fang, D Fang, PB Silver, F Wen, B Li, X Ren, Q Lin, RR Caspi, SB Su |
Investigative ophthalmology & visual science | 2010 |
Cyclophosphamide induces dynamic alterations in the host microenvironments resulting in a Flt3 ligand-dependent expansion of dendritic cells
ML Salem, AA Al-Khami, SA El-Naggar, CM Díaz-Montero, Y Chen, DJ Cole |
Journal of immunology (Baltimore, Md. : 1950) | 2010 |
Redirecting the Immune Response: Role of Adoptive T Cell Therapy
A Mondino, V Dardalhon, RH Michelini, S Loisel-Meyer, N Taylor |
Human Gene Therapy | 2010 |
Tumor-Specific CD8 + T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
SP Kerkar, P Muranski, A Kaiser, A Boni, L Sanchez-Perez, Z Yu, DC Palmer, RN Reger, ZA Borman, L Zhang, RA Morgan, L Gattinoni, SA Rosenberg, G Trinchieri, NP Restifo |
Cancer research | 2010 |
CD8+ enriched “young” tumor infiltrating lymphocytes can mediate regression of metastatic melanoma
ME Dudley, CA Gross, MM Langhan, MR Garcia, RM Sherry, JC Yang, GQ Phan, US Kammula, MS Hughes, DE Citrin, NP Restifo, JR Wunderlich, PA Prieto, JJ Hong, RC Langan, DA Zlott, KE Morton, DE White, CM Laurencot, SA Rosenberg |
Clinical cancer research | 2010 |
Putting the brakes on BTLA in T cell–mediated cancer immunotherapy
Chrystal M. Paulos, Carl H. June |
Journal of Clinical Investigation | 2009 |
Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response
GA Rizzuto, T Merghoub, D Hirschhorn-Cymerman, C Liu, AM Lesokhin, D Sahawneh, H Zhong, KS Panageas, MA Perales, G Altan-Bonnet, JD Wolchok, AN Houghton |
Journal of Experimental Medicine | 2009 |
Harnessing the physiology of lymphopenia to support adoptive immunotherapy in lymphoreplete hosts
Y Cui, H Zhang, J Meadors, R Poon, M Guimond, CL Mackall |
Blood | 2009 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function
DC Palmer, NP Restifo |
Trends in Immunology | 2009 |
Dendritic cell recovery post-lymphodepletion: a potential mechanism for anti-cancer adoptive T cell therapy and vaccination
ML Salem, DJ Cole |
Cancer Immunology, Immunotherapy | 2009 |
Recovery from Cyclophosphamide-Induced Lymphopenia Results in Expansion of Immature Dendritic Cells Which Can Mediate Enhanced Prime-Boost Vaccination Antitumor Responses In Vivo When Stimulated with the TLR3 Agonist Poly(I:C)
ML Salem, CM Díaz-Montero, AA Al-Khami, SA El-Naggar, O Naga, AJ Montero, A Khafagy, DJ Cole |
Journal of immunology (Baltimore, Md. : 1950) | 2009 |
Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination
V Radojcic, KB Bezak, M Skarica, MA Pletneva, K Yoshimura, RD Schulick, L Luznik |
Cancer Immunology, Immunotherapy | 2009 |
Toll-like receptor agonists in cancer therapy
S Adams |
Immunotherapy | 2009 |
Adoptive cell therapy for the treatment of patients with metastatic melanoma
SA Rosenberg, ME Dudley |
Current Opinion in Immunology | 2009 |
Harnessing innate and adaptive immunity for adoptive cell therapy of renal cell carcinoma
C Geiger, E Nößner, B Frankenberger, CS Falk, H Pohla, DJ Schendel |
Journal of Molecular Medicine | 2009 |
Ineffective vaccination against solid tumors can be enhanced by hematopoietic cell transplantation
A Filatenkov, AM Müller, WW Tseng, S Dejbakhsh-Jones, D Winer, R Luong, JA Shizuru, EG Engleman, S Strober |
Journal of immunology (Baltimore, Md. : 1950) | 2009 |
Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation
VT Ho, M Vanneman, H Kim, T Sasada, YJ Kang, M Pasek, C Cutler, J Koreth, E Alyea, S Sarantopoulos, JH Antin, J Ritz, C Canning, J Kutok, MC Mihm, G Dranoff, R Soiffer |
Proceedings of the National Academy of Sciences | 2009 |
Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability
PD Cani, S Possemiers, TV de Wiele, Y Guiot, A Everard, O Rottier, L Geurts, D Naslain, A Neyrinck, DM Lambert, GG Muccioli, NM Delzenne |
Gut | 2009 |
The intestinal microbiota in health and disease: the influence of microbial products on immune cell homeostasis:
MC Abt, D Artis |
Current Opinion in Gastroenterology | 2009 |
Immunotransplantation preferentially expands T-effector cells over T-regulatory cells and cures large lymphoma tumors
JD Brody, MJ Goldstein, DK Czerwinski, R Levy |
Blood | 2009 |
An Essential Role of the Forkhead-Box Transcription Factor Foxo1 in Control of T Cell Homeostasis and Tolerance
W Ouyang, O Beckett, RA Flavell, MO Li |
Immunity | 2009 |
Adjuvants targeting innate and adaptive immunity synergize to enhance tumor immunotherapy
G Verdeil, K Marquardt, CD Surh, LA Sherman |
Proceedings of the National Academy of Sciences | 2008 |
From the Cover: Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity
DC Palmer, CC Chan, L Gattinoni, C Wrzesinski, CM Paulos, CS Hinrichs, DJ Powell, CA Klebanoff, SE Finkelstein, RN Fariss, Z Yu, RB Nussenblatt, SA Rosenberg, NP Restifo |
Proceedings of the National Academy of Sciences | 2008 |
Engagement of Toll-like receptor-2 on cytotoxic T-lymphocytes occurs in vivo and augments antitumor activity
N Asprodites, L Zheng, D Geng, C Velasco-Gonzalez, L Sanchez-Perez, E Davila |
The FASEB Journal | 2008 |
Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma
SA Quezada, KS Peggs, TR Simpson, Y Shen, DR Littman, JP Allison |
Journal of Experimental Medicine | 2008 |
The nature of the lymphopenic environment dictates protective function of homeostatic-memory CD8+ T cells
SE Hamilton, SC Jameson |
Proceedings of the National Academy of Sciences | 2008 |
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
SA Rosenberg, NP Restifo, JC Yang, RA Morgan, ME Dudley |
Nature reviews. Cancer | 2008 |
Immunotherapy for Advanced Melanoma
L Fang, AS Lonsdorf, ST Hwang |
Journal of Investigative Dermatology | 2008 |
Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriers
A Boni, P Muranski, L Cassard, C Wrzesinski, CM Paulos, DC Palmer, L Gattinoni, CS Hinrichs, CC Chan, SA Rosenberg, NP Restifo |
Blood | 2008 |
Dendritic cells: a critical player in cancer therapy?
AK Palucka, H Ueno, J Fay, J Banchereau |
Journal of immunotherapy (Hagerstown, Md. : 1997) | 2008 |
Transforming Growth Factor-β Receptor Blockade Augments the Effectiveness of Adoptive T-Cell Therapy of Established Solid Cancers
A Wallace, V Kapoor, J Sun, P Mrass, W Weninger, DF Heitjan, C June, LR Kaiser, LE Ling, SM Albelda |
Clinical cancer research | 2008 |
Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses
JA Hall, N Bouladoux, CM Sun, EA Wohlfert, RB Blank, Q Zhu, ME Grigg, JA Berzofsky, Y Belkaid |
Immunity | 2008 |
Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens
ME Dudley, JC Yang, R Sherry, MS Hughes, R Royal, U Kammula, PF Robbins, JP Huang, DE Citrin, SF Leitman, J Wunderlich, NP Restifo, A Thomasian, SG Downey, FO Smith, J Klapper, K Morton, C Laurencot, DE White, SA Rosenberg |
Journal of Clinical Oncology | 2008 |
CD8+ T Cells Targeting A Single Immunodominant Epitope Are Sufficient for Elimination of Established SV40 T Antigen-Induced Brain Tumors
Tatum AM, Mylin LM, Bender SJ, Fischer MA, Vigliotti BA, Tevethia MJ, Tevethia SS, Schell TD |
Journal of immunology (Baltimore, Md. : 1950) | 2008 |
Toll-like receptors in tumor immunotherapy
CM Paulos, A Kaiser, C Wrzesinski, CS Hinrichs, L Cassard, A Boni, P Muranski, L Sanchez-Perez, DC Palmer, Z Yu, PA Antony, L Gattinoni, SA Rosenberg, NP Restifo |
Clinical cancer research | 2007 |